Login
$KYTX
$4.79 -$0.26 (5.15%) Live

Company Executives

Officer Age In this role 2025 pay Source
Warner Biddle Also a director
Chief Executive Officer and Director
59 Not stated $1,814,980
Gregory Martini
Chief Financial Officer
Title from the Form 8-K dated May 18, 2026
Not stated Not stated Not reported
Christi Shaw Also a director
Executive Chairperson
Title from the Form 4 dated May 27, 2026
59 Not stated Not reported
Naji H. Gehchan
Chief Medical and Development Officer
44 Since 2025
1 year
$2,085,173
Mayo Pujols
Chief Technology Officer
57 Since 2026
this year
Not reported
Nadia Dac
Chief Commercial Officer
Title from the Form 4 dated May 4, 2026
Not stated Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
8
serving now
Independent
6 of 6
stated in the proxy; 2 not stated
Average tenure
3.4 years
from year joined
CEO also chairs the board
No
Christi Shaw
Director Age On board Independent Committees Other public boards 2025 pay Source
Christi Shaw
59 2024
2 years
Not stated None stated Beam Therapeutics Inc. $319,892
Warner Biddle
59 2024
2 years
Not stated None stated None stated Paid as CEO
Ian Clark
65 2021
5 years
Independent
Compensation Committee Nominating and Corporate Governance Committee · Chair
None stated $259,952
Mert Aktar
47 2024
2 years
Independent
Compensation Committee Audit Committee
None stated $232,452
Andrew Miller, Ph.D.
44 2026
this year
Independent
Audit Committee
None stated Not stated
Beth Seidenberg, M.D.
69 2018
8 years
Independent
Compensation Committee · Chair
Vera Therapeutics, Inc., Sagimet Biosciences, Inc. $242,452
Fred E. Cohen, M.D., D.Phil.
69 2018
8 years
Independent
Science and Technology Committee · Chair
CareDx, Inc., Intellia Therapeutics, Inc. $237,452
Sravan Emany
48 2026
this year
Independent
Audit Committee · Chair
Assertio Holdings, Inc. Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 13, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support